The biology of JC polyomavirus
- PMID: 28493815
- DOI: 10.1515/hsz-2016-0345
The biology of JC polyomavirus
Abstract
JC polyomavirus (JCPyV) is the causative agent of a fatal central nervous system demyelinating disease known as progressive multifocal leukoencephalopathy (PML). PML occurs in people with underlying immunodeficiency or in individuals being treated with potent immunomodulatory therapies. JCPyV is a DNA tumor virus with a double-stranded DNA genome and encodes a well-studied oncogene, large T antigen. Its host range is highly restricted to humans and only a few cell types support lytic infection in vivo or in vitro. Its oncogenic potential in humans has not been firmly established and the international committee on oncogenic viruses lists JCPyV as possibly carcinogenic. Significant progress has been made in understanding the biology of JCPyV and here we present an overview of the field and discuss some important questions that remain unanswered.
Keywords: HIV/AIDS; JCPyV; PML; immune response; multiple sclerosis; virus receptors.
Similar articles
-
JC Polyomavirus Infection Reveals Delayed Progression of the Infectious Cycle in Normal Human Astrocytes.J Virol. 2020 Feb 14;94(5):e01331-19. doi: 10.1128/JVI.01331-19. Print 2020 Feb 14. J Virol. 2020. PMID: 31826993 Free PMC article.
-
ERK Is a Critical Regulator of JC Polyomavirus Infection.J Virol. 2018 Mar 14;92(7):e01529-17. doi: 10.1128/JVI.01529-17. Print 2018 Apr 1. J Virol. 2018. PMID: 29321332 Free PMC article.
-
Fifty Years of JC Polyomavirus: A Brief Overview and Remaining Questions.Viruses. 2020 Sep 1;12(9):969. doi: 10.3390/v12090969. Viruses. 2020. PMID: 32882975 Free PMC article. Review.
-
Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.mBio. 2013 Jun 11;4(3):e00247-13. doi: 10.1128/mBio.00247-13. mBio. 2013. PMID: 23760462 Free PMC article.
-
The human JC polyomavirus (JCPyV): virological background and clinical implications.APMIS. 2013 Aug;121(8):685-727. doi: 10.1111/apm.12128. Epub 2013 Jun 19. APMIS. 2013. PMID: 23781977 Review.
Cited by
-
The effect of disease modifying therapies on CD62L expression in multiple sclerosis.Mult Scler J Exp Transl Clin. 2018 Sep 20;4(3):2055217318800810. doi: 10.1177/2055217318800810. eCollection 2018 Jul-Sep. Mult Scler J Exp Transl Clin. 2018. PMID: 30263146 Free PMC article.
-
Human polyomaviruses and cancer: an overview.Clinics (Sao Paulo). 2018 Oct 11;73(suppl 1):e558s. doi: 10.6061/clinics/2018/e558s. Clinics (Sao Paulo). 2018. PMID: 30328951 Free PMC article. Review.
-
Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment.Viruses. 2021 Aug 25;13(9):1684. doi: 10.3390/v13091684. Viruses. 2021. PMID: 34578264 Free PMC article.
-
Insights into the genetic characteristics, clustering patterns, and phylogeographic dynamics of the JC polyomavirus, 1993 to 2023.Virus Res. 2024 Aug;346:199414. doi: 10.1016/j.virusres.2024.199414. Epub 2024 Jun 12. Virus Res. 2024. PMID: 38848817 Free PMC article.
-
Multiple Signatures of the JC Polyomavirus in Paired Normal and Altered Colorectal Mucosa Indicate a Link with Human Colorectal Cancer, but Not with Cancer Progression.Int J Mol Sci. 2019 Nov 27;20(23):5965. doi: 10.3390/ijms20235965. Int J Mol Sci. 2019. PMID: 31783512 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources